Atlas Trials

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

Clinical trial NCT04943042 · COMPLETED

Trial details

NCT number
NCT04943042
Sponsor
Swedish Orphan Biovitrum
Status
COMPLETED
Study type
OBSERVATIONAL
Immune ThrombocytopeniaITP
Start date
2022-02-22
Primary completion
2025-06-10
Enrollment
199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.